OBJECTIVE: To examine the correlation between heart rate variability and left ventricular mass in cyclists with an athlete's heart. METHODS: Left ventricular mass and diastolic function were determined at rest and myocardial high energy phosphates were quantified at rest and during atropine-dobutamine stress in 12 male cyclists and 10 control subjects, using magnetic resonance techniques. Ambulatory 24 hour ECG recordings were obtained, and time and frequency domain heart rate variability indices were computed. RESULTS: In the cyclists, the mean of all RR intervals between normal beats (meanNN), the SD of the RR intervals, and their coefficient of variation were significantly greater than in control subjects (p < 0.01, p < 0.01, and p < 0.05, respectively). For cyclists and control subjects, only meanNN correlated with left ventricular mass (r = 0.48, p = 0.038). The heart rate variability indices that correlated with functional or metabolic variables were: meanNN v E/A peak (the ratio of peak early and peak atrial filling rate) (r = 0.48, p = 0.039); the root mean square of successive differences in RR intervals among successive normal beats v E/A area (ratio of peak early and peak atrial filling volume) (r = 0.48, p = 0.040); percentage of successive RR intervals differing by more than 50 ms v the phosphocreatine to ATP ratio at rest (r = 0.54, p = 0. 017); and the SD of the average RR intervals during all five minute periods v the phosphocreatine to ATP ratio during stress (r = 0.60, p = 0.007). CONCLUSIONS: Highly trained cyclists have increased heart rate variability indices, reflecting increased cardiac vagal control compared with control subjects. Left ventricular mass has no major influence on heart rate variability, but heart rate variability is significantly correlated with high energy phosphate metabolism and diastolic function.
OBJECTIVE: To examine the correlation between heart rate variability and left ventricular mass in cyclists with an athlete's heart. METHODS: Left ventricular mass and diastolic function were determined at rest and myocardial high energy phosphates were quantified at rest and during atropine-dobutamine stress in 12 male cyclists and 10 control subjects, using magnetic resonance techniques. Ambulatory 24 hour ECG recordings were obtained, and time and frequency domain heart rate variability indices were computed. RESULTS: In the cyclists, the mean of all RR intervals between normal beats (meanNN), the SD of the RR intervals, and their coefficient of variation were significantly greater than in control subjects (p < 0.01, p < 0.01, and p < 0.05, respectively). For cyclists and control subjects, only meanNN correlated with left ventricular mass (r = 0.48, p = 0.038). The heart rate variability indices that correlated with functional or metabolic variables were: meanNN v E/A peak (the ratio of peak early and peak atrial filling rate) (r = 0.48, p = 0.039); the root mean square of successive differences in RR intervals among successive normal beats v E/A area (ratio of peak early and peak atrial filling volume) (r = 0.48, p = 0.040); percentage of successive RR intervals differing by more than 50 ms v the phosphocreatine to ATP ratio at rest (r = 0.54, p = 0. 017); and the SD of the average RR intervals during all five minute periods v the phosphocreatine to ATP ratio during stress (r = 0.60, p = 0.007). CONCLUSIONS: Highly trained cyclists have increased heart rate variability indices, reflecting increased cardiac vagal control compared with control subjects. Left ventricular mass has no major influence on heart rate variability, but heart rate variability is significantly correlated with high energy phosphate metabolism and diastolic function.
Authors: R J van der Geest; V G Buller; E Jansen; H J Lamb; L H Baur; E E van der Wall; A de Roos; J H Reiber Journal: J Comput Assist Tomogr Date: 1997 Sep-Oct Impact factor: 1.826
Authors: B M Pluim; H J Lamb; H W Kayser; F Leujes; H P Beyerbacht; A H Zwinderman; A van der Laarse; H W Vliegen; A de Roos; E E van der Wall Journal: Circulation Date: 1998-02-24 Impact factor: 29.690
Authors: S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek Journal: Circulation Date: 1997-10-07 Impact factor: 29.690
Authors: B C Maciel; L Gallo Júnior; J A Marin Neto; E C Lima Filho; J Terra Filho; J C Manço Journal: Cardiovasc Res Date: 1985-10 Impact factor: 10.787
Authors: Keith P George; Louise H Naylor; Greg P Whyte; Rob E Shave; David Oxborough; Daniel J Green Journal: Eur J Appl Physiol Date: 2009-10-02 Impact factor: 3.078
Authors: Jingyuan Li; Soban Umar; Marjan Amjedi; Andrea Iorga; Salil Sharma; Rangarajan D Nadadur; Vera Regitz-Zagrosek; Mansoureh Eghbali Journal: Am J Cardiovasc Dis Date: 2012-07-25
Authors: Karin Halina Greiser; Alexander Kluttig; Barbara Schumann; Cees A Swenne; Jan A Kors; Oliver Kuss; Johannes Haerting; Hendrik Schmidt; Joachim Thiery; Karl Werdan Journal: Eur J Epidemiol Date: 2009-02-07 Impact factor: 8.082
Authors: Daniel Dalos; Theresa Dachs; Constantin Gatterer; Matthias Schneider; Thomas Binder; Diana Bonderman; Christian Hengstenberg; Simon Panzer; Stefan Aschauer Journal: PLoS One Date: 2022-04-12 Impact factor: 3.240
Authors: Karin H Greiser; Alexander Kluttig; Barbara Schumann; Jan A Kors; Cees A Swenne; Oliver Kuss; Karl Werdan; Johannes Haerting Journal: BMC Cardiovasc Disord Date: 2005-11-11 Impact factor: 2.298
Authors: Lamiaa Hassan; Ljupcho Efremov; Anne Großkopf; Alexander Kluttig; Rafael Mikolajczyk; Nadja Kartschmit; Daniel Medenwald; Artjom Schott; Andrea Schmidt-Pokrzywniak; Maria E Lacruz; Daniel Tiller; Frank Bernhard Kraus; Karin H Greiser; Johannes Haerting; Karl Werdan; Daniel Sedding; Andreas Simm; Sebastian Nuding Journal: Eur J Epidemiol Date: 2022-01-03 Impact factor: 8.082